Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

Excitement mounts for first disease-modifying cystic fibrosis drugs

Nature Reviews Drug Discovery volume 10, pages 479–480 (2011)Cite this article

Subjects

Two decades on from the discovery of the cystic fibrosis gene, the first disease-modifying drug stands at the gateway to approval.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Alisa Opar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Opar, A. Excitement mounts for first disease-modifying cystic fibrosis drugs. Nat Rev Drug Discov 10, 479–480 (2011). https://doi.org/10.1038/nrd3488

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd3488

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research